|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/85 | (2006.01) |
| A01K 67/027 | (2006.01) | ||
| C07K 16/00 | (2006.01) | ||
| C07K 16/46 | (2006.01) | ||
| C07K 16/18 | (2006.01) | ||
| C12N 15/10 | (2006.01) |
| (11) | Number of the document | 3034608 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16154526.4 |
| Date of filing the European patent application | 2011-06-22 | |
| (97) | Date of publication of the European application | 2016-06-22 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-30 |
| (46) | Date of publication of the claims translation | 2019-05-27 |
| (30) | Number | Date | Country code |
| 357317 P | 2010-06-22 | US | |
| 357314 P | 2010-06-22 | US |
| (72) |
MACDONALD, Lynn, US
STEVENS, Sean, US
GURER, Cagan, US
MURPHY, Andrew J., US
HOSIAWA, Karolina A., US
|
| (73) |
REGENERON PHARMACEUTICALS, INC.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Pelės, ekspresuojančios imunoglobulino hibridinę lengvąją grandinę, turinčią žmogaus kintamąją sritį |
| MICE EXPRESSING AN IMMUNOGLOBULIN HYBRID LIGHT CHAIN WITH A HUMAN VARIABLE REGION |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 15 | 289.00 EUR |
| 2026-06-22 |